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Abstract.  Bovine capillary endothelial  (BCE) cells 
were incubated at 4°C with 5 ng/ml  t25I-basic fibro- 
blast growth factor (bFGF) to equilibrate 'z~I-bFGF with 
high affinity cell surface receptors and low affinity ma- 
trix binding sites. 67%  of the added  '25I-bFGF bound 
to the matrix and 7 % bound to receptors.  The fate of 
bound bFGF was followed after cells were incubated 
in bFGF-free medium and were shifted to 37°C to re- 
store cell metabolism.  '25I-bFGF bound to receptors 
decreased rapidly while the amount of '2~I-bFGF 
bound to matrix  was reduced more slowly. The rapid 
decrease in receptor-bound '25I-bFGF appeared to be 
due to a down-regulation of bFGF receptors; cells that 
had been treated for 5 h  with bFGF had 60%  fewer 
high affinity receptors than untreated cells. Despite the 
initial high level of '25I-bFGF binding to matrix,  most 
of this  '25I-bFGF was mobilized and metabolized 
by the cells.  '25I-bFGF  was internalized by the cells at 
37°C,  leading to a constant accumulation of '25I-bFGF 
within the cell.  Internalized bFGF was rapidly cleaved 
from an  18-kD form to a  16-kD form.  The  16-kD 
form was more slowly degraded with a half-life of 
,x,8 h.  Degradation of internalized  ~2SI-bFGF was in- 
hibited by chloroquine,  suggesting that the digestion 
occurred in a lysosomal compartment. 
The role of matrix binding  sites in the internaliza- 
tion process was investigated.  Binding to matrix  sites 
seemed not to be directly involved in the internaliza- 
tion process, since addition of heparin at a concentra- 
tion that blocked 95 % of the binding to matrix had no 
effect on the initial  rate of internalization  of bFGE 
BCE cells also released a  substance that competed 
for the binding of bFGF to matrix but not to recep- 
tors.  This substance bound to DEAE-cellulose and 
was sensitive to heparinase treatment,  suggesting that 
it was a heparinlike  molecule.  Thus,  heparinlike mole- 
cules produced by BCE cells can modulate the cellular 
interaction  with bFGF.  Matrix-associated heparinlike 
molecules bind bFGF which can later be metabolized 
by the cell, and secreted heparinlike  molecules release 
bFGF from matrices. 
URING angiogenesis  new blood vessels arise from ex- 
isting  microvessels in  response  to  soluble factors 
(Folkman,  1984). Recently several angiogenesis fac- 
tors have been purified  and have been identified  as either 
acidic or basic fibroblast growth  factor (aFGF or bFGF)' 
(Shing  et al.,  1985; Esch et al.,  1985;  Lobb et al.,  1985; 
Gospodarowicz et al., 1985; Thomas et al., 1985; Moscatel- 
li et al.,  1986b;  Presta et al.,  1986).  Presumably the FGFs 
exert their effects by interaction with high affinity cell surface 
receptors on the endothelial  cells of the microvessels.  In 
binding experiments  carried out at 4°C, two classes of bind- 
ing sites with different affinities  for bFGF have been iden- 
tified on a variety  of cultured cells including  bovine capil- 
lary endothelial  (BCE) cells (Neufeld and Gospodarowicz, 
1985;  Olwin and Hauschka,  1986;  Moenner et al.,  1986; 
1. Abbreviations used in this paper: aFGF, acidic fibroblast growth factor; 
BCE cell, bovine capillary endothelial cell; bFGF, basic fibroblast growth 
factor. 
Moscatelli, 1987). The low affinity binding appears to be due 
to cell-associated  heparinlike  molecules since it can be com- 
peted with heparin or heparan sulfate, bFGF bound to low 
affinity sites can be removed with 2 M NaC1 at neutral  pH 
(conditions  which  elute bFGF from  heparin  affinity  col- 
unms), and the low affinity binding  can be substantially  re- 
duced  by treating  the  cells  with  heparinase  (Moscatelli, 
1987). High affinity binding  is probably due to cell surface 
receptors for bFGE and bFGF bound to high affinity sites 
can be eluted from the cell with 2 M NaCI at pH 4.0 (Mos- 
catelli,  1987). High affinity binding appears to involve bind- 
ing  to two species of receptor with  molecular masses of 
125 and 145 kD (Neufeld and Gospodarowicz, 1985; Moen- 
ner et al.,  1986). 
High affinity receptors for aFGF have also been identified 
on a variety of cells (Schreiber et al.,  1985; Friesel et al., 
1986; Huang et al., 1986). The receptors for aFGF have mo- 
lecular masses similar to time receptors for bFGF (Friesel et 
al.,  1986;  Neufeld and Gospodarowicz,  1986),  and aFGF 
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receptor  (Neufeld and Gospodarowicz,  1986;  Olwin and 
Hauschka, 1986). The relationship between aFGF and bFGF 
receptors is presently unclear. 
For many hormones and growth factors, interaction with 
a cell surface receptor at 37°C leads to a rapid internalization 
of the ligand-receptor complex accompanied by a  down- 
regulation of the number of surface receptors (Carpenter and 
Cohen, 1976; Heldin et al., 1982; Massague, 1983). The in- 
ternalized .ligand-receptor complex is dissociated in endo- 
somes and the ligand is transferred to lysosomes where it is 
degraded (Brown et al., 1983).  In accordance with this mo- 
del,  the exposure of baby hamster kidney (BHK) cells to 
bFGF and exposure of mouse lung capillary endothelial cells 
to aFGF leads to the down-regulation of FGF receptors on 
these cells (Neufeld and Gospodarowicz,  1985;  Friesel et 
al.,  1986).  However,  it has been reported that there is no 
down-regulation of bFGF receptors on 3T3 cells (Olwin and 
Hauschka, 1986). 
The role of low affinity binding of bFGF and its relation- 
ship to high affinity receptors is unclear. When the binding 
of bFGF to cell-associated heparinlike molecules is blocked 
by adding an excess of heparin to the medium, there is no 
effect on the stimulation of plasminogen activator production 
by BCE cells (Moscatelli, 1987), implying that the low affin- 
ity sites have no direct role in the stimulation of the cell. It 
has been proposed that the low affinity binding may act as 
a reservoir of bFGF for the cell, prolonging the response of 
a single exposure to bFGF (Moscatelli, 1987). In the experi- 
ments presented here, the dynamics of bFGF metabolism by 
BCE cells at 37°C and the role that low affinity binding sites 
play in this process are investigated. 
It is not clear whether the heparinlike molecules involved 
in low affinity binding are heparan sulfate proteoglycans in 
the subcellular matrix, heparinlike components of the plas- 
ma membrane, or both. For the purposes of this discussion, 
the term "matrix" will refer to all of these possibilities. 
Materials and Methods 
Cell Culture 
BCE cells were obtained from the adrenal cortex of recently slaughtered cat- 
tle and grown under conditions previously described (Folkman et al., 1979; 
Gross et al.,  1982). 
Labeling of  bFGF 
bFGF  was purified  from term human placentas as previously described 
(Moscatelli et al.,  1986b; Presta et al.,  1986). Purified bFGF was labeled 
with 12Sl by the Iodo-Gen (Pierce Chemical Co., Rockford, IL) procedure 
as previously described (Neufeld and Gospodarowicz,  1985;  Moscatelli, 
1987).  ~2~I-bFGF used in these experiments bad a specific activity of ,,ol,000 
cpm/fmol. 
Determination of  Binding Constants for BCE Cells 
Confluent cultures of BCE cells on 60-ram dishes were washed three times 
with cold PBS and were incubated on an orbital shaker at 4°C with cold 
ctMEM containing 0.15% (wt/vol) gelatin, 25 mM Hepes, pH 7.5, and vari- 
ous concentrations of ~25I-bFGE After 2 h, the medium was removed and 
the cells were washed three times with PBS, twice with 1 ml 2 M  NaCl in 
20 mM Hepes, pH 7.5, and twice with  1 ml 2 M  NaCI in 20 mM sodium 
acetate,  pH 4.0.  The radioactivity released by the acid 2-M NaCI wash, 
representing t~SI-bFGF bound to high affinity sites (Moscatelli, 1987), was 
analyzed by the method of Scatchard (1949). 
~25I-bFGF Internalization Experiments 
Confluent cultures of BCE cells on 60-ram dishes (1.2-1.5  ×  106 cells) 
were washed three times with cold PBS and were incubated at 4°C on an 
orbital shaker in cold aMEM containing 0.15%  (wt/vol) gelatin, 25 mM 
Hepes,  pH 7.5,  and 5  ng/ml  ~I-bFGF.  After a  2-h incubation period, 
which allowed the ~25I-bFGF to  reach equilibrium with cellular binding 
sites, the medium was removed, cultures were washed three timos with cold 
PBS, and the medium was replaced with aMEM containing 0.15% gelatin 
and 25 mM Hopes, pH 7.5, at the appropriate temperature. Half of the cul- 
tures were incubated further at 4°C and half were transferred to an orbital 
shaker at 37°C. At various times after the change of medium, the medium 
was removed; the cells were washed three times with PBS; twice with 1 ml 
2 M NaCI in 20 mM Hepes, pH 7.5; twice with 1 ml 2 M NaCI in 20 mM 
sodium acetate, pH 4.0; and were extracted with 1 ml 0.5% Triton X-100 
in 0.1 M sodium phosphate, pH 8.1. Radioactivity in the medium, the com- 
bined neutral 2 M NaCI washes, the combined acid 2 M NaCI washes, and 
the Triton X-100 extracts was determined with a gamma scintillation counter 
(model 5210,  Packard Instrument Co., Inc., Downers Grove, IL). 
Down-Regulation of  b  FG  F Receptors 
Confluent cultures of BCE cells were incubated for 5 h at 37°C with aMEM 
containing 0,15% gelatin and either 5 ng/ml bFGF or no bFGE  Cells in- 
cubated with 5 ng/ml bFGF and half of the cells incubated in medium with- 
out bFGF were washed twice with cold 2 M NaCI in 20 mM sodium acetate, 
pH 4.0, to remove bound bFGF, and then washed three times with cold PBS. 
The remaining cells that had been incubated in medium without bFGF were 
just washed three times with cold PBS. These cells were then incubated for 
2 h at 4"C with various concentrations of s2SI-bFGF and were assayed for 
high affinity binding sites as described above. 
SDS-PAGE of  Internalized bFG  F 
BCE cells were preincubated with 5 ng/ml 12SI-bFGF for 2 h at 4"C as de- 
scribed above. The cells were transferred to an orbital shaker at 37°C to ini- 
tiate internalization. After 30 rain, the medium was removed, the cells were 
washed three times with cold 2 M NaCI in 20 mM sodium acetate, pH 4.0, 
to remove surface bound 125I-bFGF, and then three times with cold PBS. 
The medium was replaced with warm bFGF-frec aMEM containing 0.15% 
gelatin and 25 mM Hepes, pH 7.5, and the cells were returned to the orbital 
shaker at 37"C. At various times thereafter the cells were washed three times 
with cold PBS and three times with 2 M  NaCI in 20 mM sodium acetate, 
pH 4.0. The cells were scraped from the dish with a rubber policeman and 
were suspended in 0.1 ml 0.5% Triton X-IO0 in 0.1  M  sodium phosphate, 
pH 8.1. An equal volume of twofold concentrated electrophoresis sample 
buffer was added, and the mixture was immediately heated in a boiling water 
bath for 5 min. The samples were run under reducing conditions on SDS- 
PAGE with 15% polyacrylamide resolving gels (Laemmli, 1970). The gels 
were dried and exposed to Kodak (Eastman Kodak Co., Rochester, NY) 
X-omat AR film. Cells washed with the same procedure and then incubated 
in medium containing *2SI-bFGF continued to accumulate radioactivity in- 
side the cell at about the same rate as unwashed cells, demonstrating that 
the wash procedure did not harm the cells. 
Competition for Binding with Conditioned Medium 
Confluent cultures of BCE cells on 60-ram dishes were washed twice with 
PBS and were incubated at 37°C in aMEM containing 0.15% gelatin and 
25 mM Hepes, pH 7.5.  At various times, the medium was collected from 
two of the dishes, centrifuged at 200 g for 10 min, and stored at 4°C. After 
the 24-h time point was collected,  ~25I-bFGF was added to all the condi- 
tioned media to a  final concentration of 5  ng/ml. The conditioned media 
were then incubated on sister cultures of BCE cells on 60-mm dishes for 
2  h at 4°C.  t~SI-bFGF bound to low and high affinity sites on these cells 
was determined as described above. 
Heparinase Treatment and DEAE-CeUulose 
Chromatography of  Conditioned Medium 
Confluent cultures of BCE cells on 60-mm dishes were incubated in serum- 
free uMEM for 24 h at 37°C. The medium was collected and centrifuged 
at 200 g for 5 min. 5-ml aliquots of the conditioned medium were incubated 
for 6  h  at 37"C with or without  10 U/ml of Flavobacterium heparinum 
heparinase  (Sigma  Chemical  Co.,  St.  Louis,  MO).  The  reaction  was 
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pies were then passed through 1-ml DEAE-cellulose (DE 52; Whatman 
Laboratory Products Inc., Clifton, NJ) columns  equilibrated with PBS. The 
columns were washed with PBS and bound material was eluted with 0.5 M 
NaCI in 25 mM Hepes, pH 7.5.  Ten 0.3-ml fractions were collected from 
each column. Samples of  the original conditioned medium, of the nonbound 
fractions, and of the elution fractions were assayed for their ability to com- 
pete for binding of 12~I-bFGF to low affinity sites. The elution fractions 
were diluted with water so that the final NaCI concentration was 0.15 M. 
As a control, a sample of the elution buffer was diluted to the same extent 
and was used in the binding assay. '25I-bFGF and gelatin were added to 1 
ml samples of fresh aMEM, of conditioned medium, of the nonbound frac- 
tions, or of the diluted elution fractions to achieve final concentrations of 
5  ng/ml and 0.15%,  respectively. These samples were then incubated on 
BCE cells in the 16-mm wells of a 24-well plate for 2 h at 40C.  t~I-bFGF 
bound to low affinity sites on these cells was determined as described above. 
Results 
Fate of  Bound bFGF at 37°C 
BCE cells were incubated with 5 ng/ml ~25I-bFGF for 2 h at 
4°C to prebind bFGF to cellular binding sites. The cells were 
then washed with PBS, the medium was replaced with bFGF- 
free medium, and the cells were transferred to 37°C or main- 
tained  at 4°C.  The fate of the bound bFGF was followed 
for the next 24 h in four compartments: bFGF in the culture 
medium;  cell-bound  tESI-bFGF  eluted  with  2  M  NaC1  at 
neutral  pH, which  represents bFGF bound to low affinity 
sites in the matrix; cell-bound 125I-bFGF eluted with a sub- 
sequent wash with 2  M  NaCl at pH 4.0,  which represents 
bFGF bound to high  affinity receptors;  and  I25I-bFGF  re- 
leased by a subsequent extraction with 0.5%  Triton X-100, 
which represents internalized bFGE 
When the original medium was removed and replaced with 
bFGF-free medium, 74% of the tESI-bFGF originally added 
to the cultures was in a  cell-associated form, and thus re- 
mained with the cultures (67 % on low affinity matrix sites 
and 7 % on high affinity receptors). When the cells were in- 
cubated in bFGF-free medium at 37°C, there was a rapid de- 
crease in tESI-bFGF bound to high affinity sites (Fig.  1 A, .) 
with about half of the receptor-bound ~25I-bFGF disappear- 
ing  in  the  first  half hour.  By  8  and  24  h  after transfer, 
~25I-bFGF bound to receptors was decreased 82%. This de- 
crease was dependent on cell metabolism, since no change 
in receptor-bound I25I-bFGF occurred at 4°C (Fig.  1 A, o). 
After the  shift to  37°C,  ]25I-bFGF  bound  to matrix de- 
creased continuously (Fig.  1 B,  .).  ~25I-bFGF in this frac- 
tion  was depleted by  ~50%  by  1 h,  but decreased more 
slowly  after  that.  A  decrease  in  matrix-bound  t25I-bFGF 
was also seen at 4°C. When cells were incubated in FGF-free 
medium at 4°C,  20%  of the matrix-bound  125I-bFGF was 
lost from this  fraction  (Fig.  1 B,  o) and  appeared in  the 
medium (Fig.  1 C, o). Thus, part of the decrease in matrix- 
bound ~25I-bFGF at 37°C was probably due to a similar re- 
distribution of '25I-bFGF between bound and free states. At 
37°C only 4% of the  ~25I-bFGF that was originally matrix- 
associated remained matrix-bound by 8  h.  The  ~25I-bFGF 
released  into  the  medium  at  37°C  (Fig.  1  C,  e)  can ac- 
count for only 35 % of the t25I-bFGF originally bound to the 
matrix.  It is likely that the remainder of the matrix-bound 
~25I-bFGF was internalized by the cells. These results indi- 
cate that most of the matrix-bound bFGF was freely available 
for metabolism by the cell. The mechanism by which matrix- 
bound  ~25I-bFGF was internalized is unclear. 
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Figure 1.  Fate of '2SI-bFGF in various  BCE cell  fractions.  Con- 
fluent cultures of BCE cells on 60-nm dishes were incubated for 
2 h at 4°C with ctMEM containing 0.15% gelatin, 25 mM Hepes, 
pH 7.5, and 5 ng/ml  t25I-bFGF. Then the medium was removed, 
the cells were washed once with PBS, and the medium was replaced 
with ¢tMEM containing only gelatin and Hepes. Half of these cells 
were incubated further at 4°C (o) and half were incubated at 37°C 
(e). At the indicated times, the medium was removed and assayed 
for TCA-precipitable  radioactivity  (C).  The cells  were  washed 
three times with PBS, twice with 2 M NaC1 at pH 7.5 (B), and twice 
with 2 M NaCI at pH 4.0 (A). The cells were then extracted with 
0.5%  Triton X-100 (D).  The amount of radioactivity  released  in 
each of the washes and in the extract was determined.  In addition, 
the amount of TCA-soluble radioactivity detected in the medium 
was added to the amount of radioactivity  in the cell extracts (t2). 
Each point represents the average of results obtained with duplicate 
cultures. The SD for each point was <8 %. The experiment was per- 
formed three times with similar results. 
'25I-bFGF  accumulated  within  the  cell  at  an  approxi- 
mately constant rate in the first 8 h after transfer to 37°C (Fig. 
1 D, .) as seen by an increase in radioactivity that was not 
removed by washing the cells with 2 M  NaC1, at pH 7.5 or 
pH 4.0, and that could be recovered with a subsequent extrac- 
tion with 0.5% Triton X-100. No increase in this fraction was 
observed in the absence of cell metabolism at 4°C (Fig. 1 D, 
o). Over 90 % of the internalized bFGF remained in a TCA- 
precipitable form in the first 4 h after the shift to 37°C (data 
not shown). At 24 h, BCE cells contained the same amount of 
125I-bFGF as at 8 h, and 85 % of this internalized ]25I-bFGF 
was still TCA precipitable. 
The  amount  of  ]25I-bFGF  in  the  medium  increased 
abruptly in the first half hour after transfer to 37°C (Fig.  1 
C, e). All of the radioactivity in the medium was TCA pre- 
cipitable in the first hour at 37°C.  However, at 2 h and later, 
a small percentage of the radioactivity in the medium was in 
a TCA-soluble form. When this experiment was performed 
on cells incubated in 50 gM chloroquine, an inhibitor of lyso- 
somal degradation,  no TCA-soluble radioactivity appeared 
in the medium (data not shown),  suggesting that the TCA- 
soluble radioactivity represented internalized  ~25I-bFGF that 
was degraded by the  cell and  subsequently  released.  The 
amount of ICA-soluble radioactivity was added to the amount 
of ~25I-bFGF accumulated by the cells (Fig.  1 D, n) to give 
a better estimate of the rate of internalization.  It appeared 
that  '25I-bFGF had been  internalized  at an approximately 
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Figure 2.  Down-regulation of high affinity bFGF  binding sites. 
Confluent cultures of BCE cells on 60-mm dishes were incubated 
for 5 h at 37°C in ¢tMEM containing 0.15% gelatin and either 
5 ng/ml bFGF or no bFGE The cells incubated with bFGF (zx) and 
half the cells incubated without bFGF (o) were washed three times 
with 2 M NaC1 at pH 4.0 and three times with PBS. The remainder 
of the cells incubated without bFGF (o) were only washed three 
times with PBS. The cells were then used to assay high affinity  bind- 
ing sites as described in Materials and Methods. Scatehard analysis 
of the high affinity binding data is shown here. 
constant rate over the first  8 h at 37°C and continued to be 
internalized afterward. 
Down-Regulation  of  High Affinity Receptors 
The rapid decrease  in  t25I-bFGF bound to receptors after 
BCE  cells  with  prebound  ~25I-bFGF were  transferred  to 
37°C suggested that the receptors were down-regulated. To 
test if down-regulation occurs in these cells, BCE cells were 
incubated with  5  ng/ml unlabeled  bFGF  for 5  h  at 37°C. 
These cells were then washed with 2 M  NaC1 at pH 4.0 to 
remove bound bFGF and were used for binding studies at 
4°C. Scatchard analysis of the binding data revealed that the 
bFGF-treated cells had 60% fewer receptors than untreated 
cells (Fig.  2). Untreated cells washed with 2 M NaCI at pH 
4.0 had the same number of high affinity binding sites as un- 
treated cells washed with PBS, demonstrating that the wash 
procedure had no effect on the receptors (Fig.  2).  None of 
these  treatments  affected the  affinity  of the  receptors  for 
bFGF as shown by the fact that the slopes of the Scatchard 
plots were equal (Fig. 2). From the Scatchard analysis, it was 
calculated  that  cells  preincubated  with  bFGF  had  6,000 
receptors/cell with a Kd of 2.2  X  10  -H M,  untreated cells 
washed with PBS had 16,900 receptors/cell with a Kd of 2.7 
×  10-" M,  and untreated cells washed with 2  M  NaCI at 
pH 4.0 had  15,500  receptors/cell with a Kd of 2.4  X  10  -l~ 
M. Thus, exposure to bFGF caused down-regulation of bFGF 
receptors on BCE cells. 
The BCE cells treated with 5 ng/ml bFGF for 5 h at 37°C 
bound the same amount of ~25I-bFGF to matrix sites  as un- 
treated cells (data not shown). The number of low affinity 
binding sites in the matrix was apparently not altered by ex- 
posure to bFGE 
Internalized bFGF 
The fate of internalized ~25I-bFGF  was followed by autoradi- 
Figure 3. Metabolism of internalized bFGE Confluent cultures of 
BCE cells on 60-mm dishes were incubated for 2 h at 4°C  in 
ctMEM containing 0.15% gelatin, 25  mM  Hepes, pH 7.5, and 
5 ng/ml ~25I-bFGE The cells were transferred to 37°C. After 30 
min, the cells were washed three times with 2 M NaCI at pH 4.0 
and three times with PBS, the medium was replaced with bFGF-free 
medium, and the cells were incubated further at 370C. At various 
times the cells were washed three times with PBS and three times 
with 2 M NaCI at pH 4.0. The cells were extracted and the extracts 
were run on a 15 % polyacrylamide gel under reducing conditions. 
Lane 1, after preineubation at 4°C; lane 2, after 30 min at 370C; 
lanes 3-7, 30 min at 37°C followed by stripping of bound  1251- 
bFGF, and incubation in bFGF-free medium for 0.5, 1.5, 3.5, 7.5, 
or 24 h at 37°C; lane 8, cells preincubated for 2 h at 37°C with 
50 I.tM chloroquine and then treated as in lane 4. 
ography. BCE cells  were preincubated with  z25I-bFGF for 
2 h at 4°C, warmed to 37°C for 30 min to initiate  internaliza- 
tion,  washed with 2 M  NaCI at pH 4.0 to remove surface- 
bound ]25I-bFGF, and then incubated at 37°C in bFGF-free 
medium. In these cells, internalized radioactivity decreased 
with a half-life of'~8 h (data not shown). Extracts of  the cells 
made at various times after initiation of internalization were 
run on SDS-PAGE and the internalized n25I-bFGF was visu- 
alized  by  autoradiography.  The  ~25I-bFGF internalized  in 
the first half hour remained mostly in its native 18-kD form 
(Fig,  3). After 2 h, most of the 18-kD bFGF was converted 
to a  16-kD form. Subsequently, the internalized  ~25I-bFGF 
was slowly degraded to smaller forms, but some persisted in 
the  16-kD form for 24 h  (Fig.  3).  In cells that had been 
treated with 50 I~M chloroquine, the internalized ~25I-bFGF 
was not degraded (Fig.  3, lane 8), suggesting that the degra- 
dation occurs through a  lysosomal pathway. 
Effect of  Heparin on Internalization of  bFGF 
To test whether bFGF binding to cell-associated heparlnhke 
molecules has an integral role in the internalization of bFGF 
by the cells,  the ability  of BCE cells to internalize  nSI-bFGF 
was studied under conditions in which the binding of 125I- 
bFGF to matrix  was blocked.  Addition of heparin  to the 
medium can block the binding of ~25I-bFGF to matrix on 
BHK cells and BCE cells (Moscatelli,  1987).  The ability of 
BCE cells  to  internalize  ~25I-bFGF in  the  presence  of 10 
Ixg/ml heparin was investigated. 
Addition  of  10  ~tg/ml heparin  blocked  >95%  of  the 
~25I-bFGF binding to BCE cell matrix (Fig. 4 B). However, 
the  amount of 125I-bFGF bound to high affinity receptors 
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Figure 4.  Fate of ~25I-bFGF in various BCE cell fractions  in the 
presence  of heparin.  Confluent cultures of BCE cells on 60-mm 
dishes were incubated for 2 h at 4°C with ctMEM containing 0.15 % 
gelatin, 25 mM Hepes (pH 7.5), and 5 ng/ml 125I-bFGF, with (o) 
or without (o) 10 ttg/ml heparin.  The cells were then transferred 
to 37°C. At the indicated times, the medium was removed and as- 
sayed for TCA-precipitable radioactivity (C). The cells were washed 
three times with PBS, twice with 2 M NaCI at pH 7.5 (B), and twice 
with 2 M NaCI at pH 4.0 (A). The cells were then extracted with 
0.5 % Triton X-100 (D). The amount of radioactivity in each of the 
washes and in the extract was determined. Each point represents the 
average of results obtained with duplicate cultures.  SDs for each 
point were ~< 8 %. The experiment was performed twice with similar 
results. 
was only slightly lower in BCE cells exposed to heparin than 
in control cells (Fig. 4 A). Upon transfer to 37°C, 12SI-bFGF 
bound to receptors decreased rapidly both in control cells 
and in cells exposed to heparin, resulting in an 80 % reduc- 
tion by 4 h (Fig. 4 A). In the first 2 h after transfer to 37°C, 
there  was a  twofold decrease both  in  '25I-bFGF bound  to 
matrix in control cells and in the residual ~25I-bFGF bound 
to matrix on cells exposed to heparin (Fig. 4 B). After 2 h, 
there was a further decrease in ~25I-bFGF bound to matrix 
on control cells but not on cells exposed to heparin. Despite 
the dramatic difference in the amount of ~2SI-bFGF bound to 
matrix, in the first 2 h after transfer to 37°C BCE cells inter- 
nalized  ~25I-bFGF at the same rate in the presence and ab- 
sence of heparin (Fig. 4  D). After 4  and 8 h,  slightly less 
'25I-bFGF was internalized by cells exposed to heparin (Fig. 
4 D). Thus, the ability of ~2SI-bFGF to bind to cell-associ- 
ated heparinlike molecules had little effect on its initial rate 
of internalization by the cell. 
Release of  a Competitor  for Low A~nity Binding 
In cultures  of BCE cells that had been preincubated with 
~25I-bFGF at 4°C and then transferred to 37°C, there was a 
continuous decrease in  '25I-bFGF bound to matrix (Fig.  1 
B). The decrease in binding was not due to a decrease in the 
number of matrix binding sites (see above). Part of the de- 
crease  could  be  explained  by  the  internalization  of  ~25I- 
bFGF that was originally bound to matrix. However, part of 
the matrix-bound ~25I-bFGF was released into the medium 
(Fig.  1 C) and this released bFGF seemed less capable of 
rebinding to the matrix.  These results suggested that BCE 
cells might be secreting a molecule which competes for the 
i  15C 
g 





-O-"O------O.  O .....  --O 
I  I  I  I  ~,  I 
2  4  6  8  24 
Hours 
Figure 5. Competition by conditioned medium for ~25I-bFGF  bind- 
ing to BCE cells. Confluent cultures of BCE cells were incubated 
at 37°C in ¢tMEM containing 0.15% gelatin and 25 mM Hepes (pH 
7.5). At the indicated times, the medium was removed and stored 
at 4°C. ~25I-bFGF  was added to the conditioned medium to achieve 
a final concentration of 5 ng/ml and this medium was incubated on 
confluent sister cultures of BCE cells at 4°C. After a 2-h incubation 
period, high (o) and low (e) affinity binding was determined as de- 
scribed  in Materials  and Methods. 
matrix  binding  thereby  preventing  the  125I-bFGF  in  the 
medium from binding to heparinlike molecules on the cell. 
To test whether BCE cells were secreting such a molecule, 
the cells were incubated at 37°C in serum-free medium for 
various periods, and the medium was collected and used for 
binding assays at 4°C. The conditioned medium from BCE 
cells partially competed for 125I-bFGF binding to matrix but 
not for binding to receptors (Fig. 5). The extent of competi- 
tion  depended  on  the  length  of the  conditioning  period. 
Thus, BCE cells at 37°C appear to release into the medium 
a molecule which competes with the binding of bFGF to the 
matrix.  The competitor could be depleted from the condi- 
tioned medium by passing the medium over a DEAE-cellu- 
lose column (Table I). The competitor was concentrated on 
Table L Effect of DEAE-Cellulose Chromatography 
and Heparinase Treatment on the Competitor in 
Conditioned Medium 
~25I-bFGF bound to matrix 
(fmol/lO  6  cells) 
Fresh medium  215  +  2 
Conditioned medium  132 +  2 
DEAE-cellulose flow through  228 +  5 
DEAE-cellulose ¢luate  65  +  5 
DEAE-cellulose eluate (heparinase 
pretrcated)  176 -t- 11 
Confluent cultures of BCE cells were incubated 24 h  in serum-free medium. 
The conditioned medium was collected and aliquots were incubated for 6 h at 
37°C  with or  without the  addition of  l0  U/ml Flavobacterium heparinum 
heparinase. The treated conditioned media were then applied to DEAE-cellu- 
lose columns. The columns were washed with PBS and eluted with 0.5 M NaCl 
in 25 mM Hepes, pH 7.5.  The effect of various fractions on binding of t25I- 
bFGF to low affinity matrix sites was compared,  t25I-bFGF  was added to the 
samples to achieve a final concentration of 5 ng/ml and these samples were in- 
cubated on confluent cultures of BCE cells at 4°C.  After a  2-h incubation 
period,  low affinity binding was determined as described in  Materials and 
Methods. 
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ment of the conditioned medium with heparinase diminished 
the inhibitory capacity of the DEAE-cellulose eluate (Table 
I). These results suggest that the competitor is a heparinlike 
molecule. This molecule has been further characterized as 
a heparan sulfate proteoglycan (Saksela et al.,  1988). 
Discussion 
The fate of the  t25I-bFGF bound to BCE cells at first ap- 
pears  somewhat complicated due to  the presence  of two 
classes of binding sites for bFGF on these cells.  As with 
other polypeptide growth  factors  (Carpenter  and  Cohen, 
1976;  Heldin et al.,  1982;  Massague,  1983),  there was a 
rapid internalization of bFGF causing a down-regulation of 
the number of high affinity receptors on the cell. FGF recep- 
tors previously have been reported to be down-regulated on 
BHK  cells  (Neufeld  and  Gospodarowicz,  1985)  and  on 
mouse lung capillary endothelial cells (Friesel et al., 1986) 
but not on 3T3 cells (Olwin and Hauschka, 1986). However, 
in contrast to other growth factors which are rapidly de- 
graded inside the cell (King and Cuatrecasas, 1981; Heldin 
et al.,  1982;  Bowen-Pope and Ross,  1982;  Massague and 
Kelly,  1986;  Walker and Burgess,  1987),  the internalized 
bFGF accumulated in a TCA-precipitable form in the cell. 
The internalized bFGF was degraded to a 16-kD form within 
2  h  after  its  uptake  into  the  cell.  The  16-kD  form was 
degraded more slowly and a  portion persisted for ~<24 h. 
Degradation of internalized bFGF was inhibited by chloro- 
quine, a classical inhibitor of lysosomal function, implying 
that the degradation occurred through a typical lysosomal 
pathway. A  similar cleavage of 18-kD  bFGF to a  16.5-kD 
form by an acid protease has been observed in extracts of hu- 
man hepatoma cells (Klagsbrun et al., 1987). Apparently in 
BCE cells, the rate of degradation of internalized bFGF was 
slower than its rate of uptake, leading to an accumulation of 
bFGF within the cell. 
A significant aspect of the interaction of bFGF with cul- 
tured cells is the high capacity of the matrix to bind bFGE 
With >1,000,000  matrix binding sites per cell (Moscatelli, 
1987) and only 6,000-17,000 receptors per cell, most of the 
bFGF added to BCE cell cultures binds to matrix. This can 
be seen in the experiment of Fig. 1 where after a 2-h preincu- 
bation with 5 ng/ml ~25I-bFGF at 4°C, ,x,67%  of the bFGF 
added to the culture was bound to matrix while 7%  was 
bound to receptors.  This high level of matrix binding may 
permit the cells to retain most of their bFGF despite fluctua- 
tions in the amount of bFGF in the fluid phase. Thus, when 
the medium of the BCE cell cultures was replaced with FGF- 
free medium, only 26 % of the bFGF originally added was 
lost. However,  the matrix-bound bFGF seems to be easily 
mobilized. After an 8-h incubation at 37°C, only 4% of the 
bFGF originally associated with the matrix remained matrix 
bound.  Thus,  despite  the extensive binding of exogenous 
bFGF to the matrix, most of this bound bFGF is still avail- 
able for interaction with the cells. 
Although the matrix-bound bFGF may serve as a source 
of bFGF which eventually binds to high affinity sites and is 
internalized by the cell, the mechanism by which this occurs 
is unclear. One possibility is that there is a direct transfer of 
bFGF  from  the  cell-associated  heparinlike  molecules  to 
receptors.  Such an  interaction would facilitate binding of 
bFGF to the receptors and, as a consequence, would enhance 
uptake of bFGF by the cell.  However,  the matrix binding 
sites did not seem to have a direct role in the internalization 
process. Internalization of bFGF proceeded at the same rate 
in cultures with bFGF bound to matrix and in cultures with 
95 % of the matrix binding blocked. This suggests that there 
is  no  direct  coupling  between  the  majority of the  cell- 
associated  heparinlike  molecules  and  the  high  affinity 
receptors. 
As would be expected from its binding to heparin (Shing 
et al., 1984; Gospodarowicz et al., 1984) and cell-associated 
heparinlike molecules (Moscatelli,  1987),  bFGF has been 
found in isolated extracellular matrices (Shing et al., 1984; 
Hauschka et al.,  1986;  Vlodavsky et al.,  1987a; Jeanny et 
al.,  1987).  It has been proposed that extracellular matrix- 
bound bFGF represents a storage form of bFGF and that it 
can be liberated by the action of heparinase-like enzymes in 
order to stimulate endothelial cell proliferation (Baird and 
Ling, 1987; Vlodavsky et al.,  1987a).  Alternatively, bFGF 
may be taken up from these sites by neighboring cells with 
high affinity receptors for bFGF simply by mass action move- 
ment of molecules from sites with lower affinity to sites with 
higher affinity.  When unoccupied receptors appear on the 
surface of cells, they would bind free bFGF from the fluid 
phase altering the equih'brium between bound and free bFGF. 
bFGF would be displaced from the matrix to restore the 
equilibrium. While the experiments presented here do not 
distinguish between these two possibilities, they do suggest 
that matrix-bound bFGF is freely available to high affinity 
receptors on BeE cells. 
The metabolism of bFGF by BeE cells is further compli- 
cated by the release from the cells of a competitor of bFGF 
binding to matrix. The competition could be due either to 
secretion of a bFGF-like molecule by the cells or to the re- 
lease  of a  bFGF-binding  molecule.  Cultured endothelial 
cells have been shown to produce bFGF (Moscatelli et al., 
1986a; Schweigerer et al., 1987; Vlodavsky et al., 1987b), 
but it appears that most of the bFGF produced by endothelial 
cells  remains cell-associated and is  not released into the 
medium. Furthermore, the competition obtained with condi- 
tioned medium seems not to be due to endothelial cell-de- 
rived bFGF because there was little competition with recep- 
tor binding. Unlabeled bFGF secreted by the cells would be 
expected to compete with receptor binding at lower concen- 
trations than axe necessary for competition with matrix bind- 
ing (MoscateUi, 1987).  However,  the competition obtained 
with conditioned medium does resemble the competition ob- 
tained with heparin (Moscatelli,  1987),  where concentra- 
tions that competed for 95 % of the binding to low affinity 
sites had little effect on high affinity binding. The competitor 
from conditioned medium has been partially purified, and 
has been biochemically characterized as a heparan sulfate 
proteoglycan (Saksela et al.,  1988). 
These released heparan sulfate proteoglycans can remove 
bFGF from matrix binding sites, and thus present another 
means of nonenzymatically mobilizing bFGF from storage 
sites in the extracellular matrix. It has been demonstrated 
that bFGF bound to heparin is much less sensitive to denatu- 
ration (Gospodarowicz and Cheng,  1986).  The endothelial 
cell-derived heparan  sulfate proteoglycans have a  similar 
protective effect, preventing degradation of bFGF by proteo- 
lytic enzymes (Saksela et al.,  1988).  In vivo, the released 
The Journal of Cell Biology, Volume  107, 1988  758 heparan sulfate proteoglycans  may serve as carrier mole- 
cules  for  bFGF,  facilitating  the  distribution  of  bFGF 
throughout the body while protecting  it from degradation. 
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